REGENXBIO Inc. (RGNX)
7.45
0.40 (5.67%)
At close: Jan 15, 2025, 3:59 PM
7.50
0.67%
After-hours Jan 15, 2025, 06:53 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -263.49M | -280.32M | 127.84M | -111.25M | -94.73M | 99.94M | -73.17M | -62.97M | -22.81M | -4.00M | -5.39M |
| Depreciation & Amortization | 17.32M | 12.91M | 9.56M | 8.41M | 7.15M | 3.98M | 2.69M | 544.00K | 80.00K | n/a | n/a |
| Stock-Based Compensation | 40.27M | 40.79M | 38.81M | 31.95M | 26.85M | 16.64M | 10.61M | 7.03M | 2.92M | 319.00K | n/a |
| Other Working Capital | -12.03M | -9.63M | -899.00K | 2.39M | -600.00K | 3.90M | -86.00K | 1.15M | 220.00K | 153.00K | -2.45M |
| Other Non-Cash Items | -1.61M | 5.16M | 4.36M | -1.23M | -2.68M | -8.93M | -347.00K | -399.00K | 13.00K | 175.00K | -289.00K |
| Deferred Income Tax | n/a | n/a | -1.92M | 3.84M | -38.97M | 794.00K | 1.34M | 2.00M | 322.00K | n/a | n/a |
| Change in Working Capital | -10.89M | 13.98M | 40.22M | 14.22M | -5.33M | -7.77M | 897.00K | 5.23M | -3.04M | 1.11M | 2.66M |
| Operating Cash Flow | -218.41M | -207.49M | 218.88M | -54.06M | -107.70M | 104.65M | -57.99M | -48.56M | -22.52M | -2.40M | -3.01M |
| Capital Expenditures | -9.96M | -30.72M | -84.17M | -26.87M | -11.72M | -13.28M | -7.16M | -8.15M | -522.00K | n/a | n/a |
| Acquisitions | n/a | n/a | -4.99M | -149.63M | -295.98M | -179.71M | -479.00K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -86.56M | -184.88M | -498.14M | -123.04M | -190.74M | -445.83M | -68.63M | -45.07M | -163.28M | n/a | n/a |
| Sales Maturities Of Investments | 287.47M | 203.67M | 175.68M | 272.67M | 296.01M | 179.75M | 71.00M | 72.61M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 0.00 | 4.99M | 149.63M | 295.98M | 179.71M | 479.00K | -225.00K | -163.28M | n/a | n/a |
| Investing Cash Flow | 190.94M | -11.93M | -406.64M | 122.76M | 93.56M | -279.36M | -4.79M | 19.16M | -163.80M | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.40M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -41.67M | -30.58M | -22.96M | 198.41M | 7.06M | 13.88M | 2.05M | 119.00K | 94.13M | 1K | 1.97M |
| Financial Cash Flow | -34.97M | -28.84M | 195.25M | 200.21M | 8.38M | 204.44M | 84.60M | 119.00K | 239.31M | 2.40M | 1.97M |
| Net Cash Flow | -62.43M | -248.26M | 7.48M | 268.91M | -5.77M | 29.73M | 21.82M | -29.28M | 52.99M | 2.00K | -1.05M |
| Free Cash Flow | -228.37M | -238.21M | 134.70M | -80.93M | -119.42M | 91.37M | -65.15M | -56.71M | -23.04M | -2.40M | -3.01M |